Cantoni Therapeutics
PrivateLast Round
Seed
Sep 16, 2025
Company Overview
Cantoni Therapeutics operates in Healthcare & Life Sciences and is based in Oss. Its latest recorded funding round was a Seed round in September 2025.
Cantoni Therapeutics is a biotechnology company developing small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) for the treatment of obesity and its comorbidities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cantoni Therapeutics Comparables
Compare Cantoni Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eolo Pharma | 83% | |
| Ridgeline Therapeutics | 78% | |
| Deep Apple Therapeutics | 77% |
For institutional investors. Book with your work email.
Cantoni Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 16, 2025 | ||||
| Pre Seed | Dec 1, 2022 |
For institutional investors. Book with your work email.
Cantoni Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Brabantse Ontwikkelings Maatschappij | Seed |
| Libertatis Ergo Holding | Pre Seed, Seed |
| Brabant Startup Fonds | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2025
Led by Libertatis Ergo Holding with participation from Brabant Startup Fonds and Brabantse Ontwikkelings Maatschappij.
- Sep 19, 2024
Grew 75% QoQ, from 4 to 7 employees.
For institutional investors. Book with your work email.
Cantoni Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cantoni Therapeutics's valuation, stock price, and market status.
Is Cantoni Therapeutics a public or private company?
Cantoni Therapeutics is a private company.
What is the current stock price of Cantoni Therapeutics?
Cantoni Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cantoni Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cantoni Therapeutics worth (valuation)?
Valuation information for Cantoni Therapeutics is not publicly available.
Can I buy Cantoni Therapeutics stock?
Cantoni Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cantoni Therapeutics's last funding round?
Cantoni Therapeutics's most recent funding round was Seed on September 16, 2025.
Who are the main investors in Cantoni Therapeutics?
Key investors in Cantoni Therapeutics include Libertatis Ergo Holding.
Will Cantoni Therapeutics IPO soon?
No public IPO plans have been announced for Cantoni Therapeutics.
How can I track Cantoni Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cantoni Therapeutics's shares on secondary markets.